GR1000618B - Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων. - Google Patents

Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων.

Info

Publication number
GR1000618B
GR1000618B GR900100189A GR900100189A GR1000618B GR 1000618 B GR1000618 B GR 1000618B GR 900100189 A GR900100189 A GR 900100189A GR 900100189 A GR900100189 A GR 900100189A GR 1000618 B GR1000618 B GR 1000618B
Authority
GR
Greece
Prior art keywords
derivatives
nucleosidic
associations
hiv
hiv suppression
Prior art date
Application number
GR900100189A
Other languages
Greek (el)
English (en)
Other versions
GR900100189A (en
Inventor
Vera Brankovan
J Richard White
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of GR900100189A publication Critical patent/GR900100189A/el
Publication of GR1000618B publication Critical patent/GR1000618B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR900100189A 1989-03-17 1990-03-14 Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων. GR1000618B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32493489A 1989-03-17 1989-03-17
US40190889A 1989-09-01 1989-09-01

Publications (2)

Publication Number Publication Date
GR900100189A GR900100189A (en) 1990-07-31
GR1000618B true GR1000618B (el) 1992-08-31

Family

ID=26984692

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100189A GR1000618B (el) 1989-03-17 1990-03-14 Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων.

Country Status (19)

Country Link
EP (1) EP0464137A4 (fr)
JP (1) JPH04504850A (fr)
KR (1) KR920700653A (fr)
CN (1) CN1045791A (fr)
AU (1) AU5351490A (fr)
CA (1) CA2050473A1 (fr)
DD (1) DD301787A9 (fr)
FI (1) FI914367A0 (fr)
GR (1) GR1000618B (fr)
HU (1) HU208254B (fr)
IL (1) IL93783A0 (fr)
NO (1) NO913659L (fr)
NZ (1) NZ232912A (fr)
OA (1) OA09555A (fr)
PL (1) PL284343A1 (fr)
PT (1) PT93449A (fr)
WO (1) WO1990011081A1 (fr)
YU (1) YU53790A (fr)
ZW (1) ZW3290A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
CA2335617C (fr) * 1998-06-24 2009-12-15 Emory University 3'-azido-2',3'-dideoxyuridine (cs-87) utilise en combinaison avec d'autres medicaments anti-vih pour la fabrication d'un medicament destine a traiter le vih
AU2002255707A1 (en) 2001-03-15 2002-10-03 Trustees Of Boston College, The Selective anti-viral nucleoside chain terminators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001284A1 (fr) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition du caractere infectieux et de l'effet cytopathique du htlv-iii/lav in vitro par la 2',3'-dideoxyinosine, 2',3'-dideoxyguanosine, ou 2',3'-dideoxyadenosine
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Also Published As

Publication number Publication date
OA09555A (en) 1993-01-31
HUT57988A (en) 1992-01-28
PL284343A1 (en) 1991-06-03
NO913659D0 (no) 1991-09-17
EP0464137A1 (fr) 1992-01-08
ZW3290A1 (en) 1990-11-07
JPH04504850A (ja) 1992-08-27
CN1045791A (zh) 1990-10-03
CA2050473A1 (fr) 1990-09-18
GR900100189A (en) 1990-07-31
YU53790A (sh) 1993-05-28
NO913659L (no) 1991-10-18
FI914367A0 (fi) 1991-09-17
HU208254B (en) 1993-09-28
PT93449A (pt) 1990-11-07
DD301787A9 (de) 1994-01-13
NZ232912A (en) 1992-06-25
KR920700653A (ko) 1992-08-10
AU5351490A (en) 1990-10-22
EP0464137A4 (en) 1992-01-15
IL93783A0 (en) 1990-12-23
WO1990011081A1 (fr) 1990-10-04
HU902898D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
ES2138969T3 (es) Combinacion de nucleosidos antivirales.
ES2149267T3 (es) Carbonilos ciclicos substituidos y derivados de los mismos utiles como inhibidores de la proteasa retroviral.
RU93043875A (ru) 1-(2-гидроксиметил)-1,3-оксатиолан-5-ил)-5-фторцитозин и способ лечения
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
DK92788A (da) Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira
ES2108969T3 (es) Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales.
TW371662B (en) Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives
ES2053953T3 (es) Uso de fracciones de heparina o fragmentos de heparina.
ES2081491T3 (es) Nuevo polipeptido y farmaco anti-vih preparado a partir de este polipeptido.
GR1000618B (el) Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων.
NO883375D0 (no) Farmasoeytiske kombinasjonspreparater samt deres fremstilling og anvendelse.
MX9203217A (es) Nucleosidos terapeuticos.
ES2134259T3 (es) Compuestos antiviricos calanolidas, composiciones y utilizacion de los mismos.
ES2103577T3 (es) Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos.
DE68927651D1 (de) Derivate von Fluorphosphonat-Nukleotiden
DE3580639D1 (de) Zubereitungen und verfahren zum schutz von t-lymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
ITMI920132A1 (it) Derivati della 8-(1-amminocicloalchil)1, 3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
DE68929084D1 (de) Arzneimittel zur Verhinderung einer Infektion mit dem für AIDS verantwortlichen Virus
KR920019362A (ko) 디데옥시 아데노신 및 아데노신 데아미나제 억제물질을 포함하는, 항-hiv활성을 지닌 치료학적 조성물
TH10132A (th) การยับยั้งไวรัสที่ทำให้เกิดภูมิคุ้มกันบกพร่องในคน (hiv) โดยการทำงานร่วมกันแบบเสริมของอนุพันธุ์นิวคลีโอไซด์
WO1988008707A3 (fr) Derives de rubradirine pour le traitement de l'infection hiv
TH10132EX (th) การยับยั้งไวรัสที่ทำให้เกิดภูมิคุ้มกันบกพร่องในคน (hiv) โดยการทำงานร่วมกันแบบเสริมของอนุพันธุ์นิวคลีโอไซด์